RTIX Financial Facts
Marketing, general and administrative: 15.02MWeighted average shares outstanding - diluted: 56.29M
See Full Income Statement
Other long-term liabilities: 695K
Long-term obligations - less current portion: 0
See Full Balance Sheet
Earnings History for RTI Biologics, Inc. (RTIX)
|
Expand Research on RTIX
| Next EPS Date | 7/30/13 *Est. | EPS Growth Rate | -25.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +25.0% | Revenue Growth Rate | -7.6% *Last Qtr. |
| Average % Move 1-Wk after EPS | -3.0% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/13  |
 |
Q113 | $0.03 | $0.02 | +$0.01 | $40.4M | $38.76M | N/A / N/A | = | 0% | Details |
| 2/7/13 | Q412 | $0.04 | $0.04 | $0.00 | $44.6M | $45.14M | N/A / N/A | = | -14.3% | Details | |
| 10/25/12 |
|
Q312 | $0.05 | $0.04 | +$0.01 | $44.6M | $44.16M | N/A / N/A |  |
-4.9% | Details |
| 7/31/12 |
|
Q212 | $0.05 | $0.04 | +$0.01 | $45.2M | $44.24M | N/A / N/A | = | +18.7% | Details |
| 4/26/12 | |
Q112 | $0.04 | $0.03 | +$0.01 | $43.7M | $41.91M | N/A / N/A | |
+11.5% | Details |
| 1/31/12 |
|
Q411 | $0.04 | $0.03 | +$0.01 | $42.9M | $41.24M | N/A / N/A | |
+1.8% | Details |
| 10/27/11 |
|
Q311 | $0.05 | $0.03 | +$0.02 | $42.3M | $40.44M | N/A / N/A | = | +2.3% | Details |
| 7/28/11 |
|
Q211 | $0.04 | $0.03 | +$0.01 | $43.5M | $40.48M | N/A / N/A | = | +36.2% | Details |
